Vasovist

Active Ingredient(s): Gadofosveset Trisodium
FDA Approved: * December 22, 2008
Pharm Company: * EPIX PHARMA
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Vasovist Overview

Gadofosveset (trade names Vasovist, Ablavar) is a gadolinium-based MRI contrast agent. It was used as the trisodium salt monohydrate form.[1][2] It acts as a blood pool agent by binding to human serum albumin. The manufacturer (Lantheus Medical) discontinued production in 2017 due to poor sales.[3] References ^ DailyMed: Vasovist ^ Drugs.com: Ablavar ^ Bell, Daniel; Morgan, Matt. "Gadofosveset trisodium". Radiopaedia. radiopaedia.org. Ret...

Read more Vasovist Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gadofosveset

Recent Vasovist Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Gadofosveset Trisodium
  • Injection: 244mg
  • Solution: 2440mg/10ml (244mg/ml), 3660mg/15ml (244mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Gadofosveset Trisodium or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA